CLOCK is found to be upregulated in most tumours, while BMAL1, PER1, CRY2, PER3, CRY1, NR1D1 and NR1D2 appear to be downregulated (Ortega‐Campos et al. 2023). Here, CLOCK is linked to neoplasm.